Affiliation:
1. Helen Keller International
2. National Institute of Ophthalmology and Hospital (NIOH)
3. Shaheed Ziaur Rahman Medical College, SZMC
4. Mymensingh Medical College Hospital
5. Global Alliance for Vaccine and Immunization
Abstract
Abstract
Background and aim:
While early detection and timely treatments can prevent diabetic retinopathy (DR) related blindness, barriers to receiving these DR services may cause permanent sight loss. Despite having similar prevalence to diabetes and DR, women are less likely than men to perform these behaviors due to multi-faced barriers in screening and receiving follow-up treatment for DR. This study, therefore aimed at identifying the barriers to – and enablers of – screening and follow-up treatments behaviors for DR among women aged more than 40 years with diabetes from the behavioral perspectives in Bangladesh.
Methods
This Barrier Analysis study interviewed 360 women (180 “Doers” and 180 “Non-doers”) to explore twelve behavioral determinants of four DR behaviors including screening, injection of anti-vascular endothelial growth factor (anti-VEGF medication), laser therapy and vitro-retinal surgery. The data analysis was performed to calculate estimated relative risk to identify the degree of association between the determinants and behaviors, and to find statistically significant differences (at p < 0.05) in the responses between the Doers and Non-doers.
Results
Access to healthcare facilities was the major barrier impeding women from performing DR behaviors. Difficulty in locating DR service centers, the need to travel long distances, the inability to travel alone and during illness, and challenges of paying for transportation and managing workload significantly affected ability to perform the behaviors. Other determinants included women’s perceived self-efficacy, perceived negative consequences (e.g. fear and discomfort associated with injections or laser treatment), and cues for action. Significant perceived enablers included low cost of DR treatments, supportive attitudes by healthcare providers, government policy, and perceived social norms.
Conclusion
Further investments are required to enhance the availability of DR services within primary and secondary health institutions along with health behavior promotion to dispel misconceptions and fears related to DR treatments.
Publisher
Research Square Platform LLC
Reference36 articles.
1. IDF. IDF DIABETES ATLAS: Eighth edition 2017 [Internet]. IDF Diabetes Atlas, 8th edition. 2017. 1–150 p. Available from: https://diabetesatlas.org/upload/resources/previous/files/8/IDF_DA_8e-EN-final.pdf
2. Klein R, Klein BEK. The Epidemiology of Diabetic Retinopathy [Internet]. Fifth Edit. Vol. 2, Retina Fifth Edition. Elsevier Inc.; 2012. 907–924 p. Available from: http://dx.doi.org/10.1016/B978-1-4557-0737-9.00045-X
3. Global prevalence and major risk factors of diabetic retinopathy;Yau JWY;Diabetes Care,2012
4. Teo ZL, Tham Y-C, Yu M, Chee ML, Rim TH, Cheung N et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology [Internet]. 2021 Nov 1 [cited 2021 Oct 31];128(11):1580–91. Available from: http://www.aaojournal.org/article/S0161642021003213/fulltext
5. Trends in Diabetic Retinopathy, Visual Acuity, and Treatment Outcomes for Patients Living With Diabetes in a Fundus Photograph-Based Diabetic Retinopathy Screening Program in Bangladesh;Muqit MMK;JAMA Netw open,2019